NCT06188793
Virtual Reality (VR) -Directed Brain Gut Behavioral Treatment (BGBT) for Inflammatory Bowel Disease (IBD) Inpatients
At risk: Primary completion moved at least 2 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 8 words
- Primary completion pushed from Sep 2026 to Dec 2026
- Secondary endpoints: details revised at 2 of 3 entries
- Publications: details revised at 1 of 1 entry
- Minor Primary completion pushed from May 2026 to Sep 2026
- Study completion pushed from May 2026 to Dec 2026
- Minor Primary and study completion dates: Feb 2026 to May 2026v4
- Notable Primary and study completion dates: Jul 2025 to Feb 2026v3
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Jan 2024 to Feb 13, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Feasibility of the intervention measured as the frequency (percentage) of enrolled participants that complete the VR-directed BGBT inpatient program
Timeframe: 3 days of treatment
Secondary (3)
Intervention acceptability based on qualitative data and collected from audio-recordings of semi-structured interview
Acceptability using the System Usability Scale - patients
Acceptability using the Treatment Acceptance and Adherence Scale- patients
Arms and interventions
Virtual reality-directed BGBTExperimental
Devices: Virtual reality-directed BGBT
Sites
1 site in 1 country
- University of MichiganAnn Arbor, Michigan, United States